Milestone Alert: Biofrontera Inc. Places 100th RhodoLED XL Machine in U.S. Market
Biofrontera Inc. has installed the 100th commercial RhodoLED XL Lamp in the U.S. market. The RhodoLED XL was approved by the U.S. Food and Drug Administration (FDA) for use in combination with aminolevulinic acid HCl (Ameluz) in 2022 and was launched in June 2024. Ameluz is used in combination with photodynamic therapy using BF-RhodoLED or RhodoLED […]